From: Antibiotic consumption in long-term care facilities in Poland and other European countries in 2017
Antibacterials for systemic use, anatomical therapeutic chemical classification | HALT PPS (n;%) [9] | |||
---|---|---|---|---|
Total | Poland | |||
N (%) | AMC** | N (%) | AMC** | |
Tetracyclines, J01A | 105 (2.1) | 1.03 | 1 (1.4) | 0.44 |
Amphenicols, J01B | 2 (0.0) | 0.02 | 0 (0.0) | 0.00 |
Beta-lactams, penicillins, J01C | 1515 (29.8) | 14.81 | 20 (27.4) | 8.77 |
Other beta-lactams, J01D | 639 (12.6) | 6.25 | 16 (21.9) | 7.01 |
Sulfonamides and trimethoprim, J01E | 724 (14.2) | 7.08 | 3 (4.1) | 1.32 |
Macrolides, lincosamides and streptogramins, J01F | 369 (7.3) | 3.61 | 3 (4.1) | 1.32 |
Aminoglycosides, J01G | 34 (0.7) | 0.33 | 5 (6.8) | 2.19 |
Quinolones, J01M | 752 (14.8) | 7.35 | 12 (16.4) | 5.26 |
Combinations of antibacterials, J01R | 9 (0.2) | 0.09 | 0 (0.0) | 0.00 |
Other antibacterials, J01X* | 939 (18.5) | 9.18 | 13 (17.8) | 5.70 |
Total | 5.088 (100.0) | 49.74 | 73 (100.0) | 32.00 |